AVENUE THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

AVENUE THERAPEUTICS, INC. (ATXI) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 135.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2026-03-30

AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2024 was 135.00%, a 7.40% increase from fiscal 2023.
AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2023 was 125.70%.
AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2022 was 0.00%.

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 0 month	Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month	Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month	Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month as first filed
2024-12-31			135.00% 10-K · filed 2026-03-30
2023-12-31			125.70% 10-K · filed 2025-03-31	125.72% 10-K · filed 2024-03-18
2022-12-31			0.00% 10-K · filed 2024-03-18
2017-09-30		80.00% 10-Q · filed 2017-11-09
2017-08-15	80.00% 10-K · filed 2019-03-12